- Home
- NXPLW vs ZSPC Comparison
NXPLW vs ZSPC Comparison
Compare NXPLW & ZSPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- ZSPC
- Stock Information
- Founded
- NXPLW N/A
- ZSPC 2007
- Country
- NXPLW United States
- ZSPC United States
- Employees
- NXPLW 166
- ZSPC N/A
- Industry
- NXPLW Telecommunications Equipment
- ZSPC
- Sector
- NXPLW Telecommunications
- ZSPC
- Exchange
- NXPLW Nasdaq
- ZSPC NYSE
- Market Cap
- NXPLW N/A
- ZSPC N/A
- IPO Year
- NXPLW N/A
- ZSPC 2024
- Fundamental
- Price
- NXPLW N/A
- ZSPC $8.70
- Analyst Decision
- NXPLW
- ZSPC Strong Buy
- Analyst Count
- NXPLW 0
- ZSPC 3
- Target Price
- NXPLW N/A
- ZSPC $13.67
- AVG Volume (30 Days)
- NXPLW 6.4K
- ZSPC 62.0K
- Earning Date
- NXPLW 03-31-2025
- ZSPC 05-15-2025
- Dividend Yield
- NXPLW N/A
- ZSPC N/A
- EPS Growth
- NXPLW N/A
- ZSPC N/A
- EPS
- NXPLW N/A
- ZSPC 1.03
- Revenue
- NXPLW $66,482,000.00
- ZSPC $38,098,000.00
- Revenue This Year
- NXPLW N/A
- ZSPC $0.55
- Revenue Next Year
- NXPLW N/A
- ZSPC $54.93
- P/E Ratio
- NXPLW N/A
- ZSPC $8.47
- Revenue Growth
- NXPLW 179.89
- ZSPC N/A
- 52 Week Low
- NXPLW $0.25
- ZSPC $5.25
- 52 Week High
- NXPLW $0.26
- ZSPC $32.69
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- ZSPC N/A
- Support Level
- NXPLW N/A
- ZSPC N/A
- Resistance Level
- NXPLW N/A
- ZSPC N/A
- Average True Range (ATR)
- NXPLW 0.00
- ZSPC 0.00
- MACD
- NXPLW 0.00
- ZSPC 0.00
- Stochastic Oscillator
- NXPLW 0.00
- ZSPC 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.